News
Gufic BioSciences receives ESG rating of 62
28-Sep-2026 | 19:17
Gufic BioSciences announced that Crisil ESG Ratings & Analytics (Crisil), a SEBI Registered Category - I Environmental, Social and Governance (ESG) Rating Provider vide its report dated 25 September 2026, received by the Company on 28 September 2026, has assigned an overall ESG rating of CRISIL ESG 62 (Category: Strong) to the Company for FY 2025-26.